Comparison of two methods for enumerating circulating tumor cells in carcinoma patients
- PMID: 16142788
- DOI: 10.1002/cyto.b.20065
Comparison of two methods for enumerating circulating tumor cells in carcinoma patients
Abstract
Background: Monitoring of circulating tumor cells (CTCs) in blood of carcinoma patients treated with novel compounds may be a measurement of treatment effectiveness. Before it can be used clinically, a reliably method is needed to enumerate CTCs. We compared two methods for CTC enumeration, OnkoQuick and the CellSearch system.
Methods: We drew 22.5 ml of blood into three CellSave tubes from 15 healthy donors and 61 patients with metastatic carcinoma. After pooling, 15 ml was processed with OncoQuick and 7.5 ml with CellSearch.
Results: With both methods no CTCs were found in healthy donors. At least one CTC was detected in 14 of 61 patients (23%) with OncoQuick and 33 of 61 patients (54%) with CellSearch (P < 0.0001). The number of CTCs detected was larger for CellSearch (mean 20 CTCs/7.5 ml of blood) than for OncoQuick (3 CTCs/7.5 ml; P < 0.0001).
Conclusion: The CellSearch system is a more accurate and sensitive method to enumerate CTCs. Further studies are warranted to evaluate CTC enumeration by the CellSearch system as a monitoring tool for the evaluation of the efficacy of novel anticancer agents.
(c) 2005 Wiley-Liss, Inc.
Similar articles
-
Detection of circulating urothelial cancer cells in the blood using the CellSearch System.Cancer. 2007 Apr 1;109(7):1439-45. doi: 10.1002/cncr.22543. Cancer. 2007. PMID: 17326057
-
Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.Ann Surg Oncol. 2008 Nov;15(11):3092-100. doi: 10.1245/s10434-008-0122-9. Epub 2008 Sep 3. Ann Surg Oncol. 2008. PMID: 18766405
-
Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.Ann Surg Oncol. 2007 Dec;14(12):3359-68. doi: 10.1245/s10434-007-9538-x. Epub 2007 Sep 29. Ann Surg Oncol. 2007. PMID: 17906897
-
Image cytometry analysis of circulating tumor cells.Methods Cell Biol. 2011;102:261-90. doi: 10.1016/B978-0-12-374912-3.00010-9. Methods Cell Biol. 2011. PMID: 21704842 Review.
-
Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer.Mol Pharm. 2009 Sep-Oct;6(5):1307-10. doi: 10.1021/mp900088r. Mol Pharm. 2009. PMID: 19634916 Review.
Cited by
-
Detection of circulating tumor cells: Clinical relevance of a novel metastatic tumor marker.Exp Ther Med. 2011 May;2(3):385-391. doi: 10.3892/etm.2011.234. Epub 2011 Mar 21. Exp Ther Med. 2011. PMID: 22977514 Free PMC article.
-
Circulating tumor cells measurements in hepatocellular carcinoma.Int J Hepatol. 2012;2012:684802. doi: 10.1155/2012/684802. Epub 2012 May 28. Int J Hepatol. 2012. PMID: 22690340 Free PMC article.
-
Treatment for non-small-cell lung cancer and circulating tumor cells.Lung Cancer Manag. 2017 Dec;6(4):129-139. doi: 10.2217/lmt-2017-0019. Epub 2018 Jun 22. Lung Cancer Manag. 2017. PMID: 30643579 Free PMC article. Review.
-
Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.Br J Cancer. 2010 Jan 19;102(2):276-84. doi: 10.1038/sj.bjc.6605472. Epub 2009 Dec 1. Br J Cancer. 2010. PMID: 19953098 Free PMC article.
-
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study.Gynecol Oncol. 2011 Oct;123(1):19-26. doi: 10.1016/j.ygyno.2011.06.022. Epub 2011 Jul 12. Gynecol Oncol. 2011. PMID: 21752435 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous